95
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Elimination of Low-Osmolality Contrast Media by Hemodialysis

, , &
Pages 966-971 | Accepted 12 Apr 1996, Published online: 07 Jan 2010

References

  • von Baars H.-G., Schabel J., Weiss M. Kontrastmittel-Elimination durch Hämodialyse. Z. Urol. Nephrol. 1984; 77: 473
  • Bahlmann J., Krüskemper H. L. Elimination of iodine-containing contrast media by haemodialysis. Nephron 1973; 10: 250
  • Bourin M., Laporte V., Guenzet J., Langlois S., Pengloan J., Rouleau P. Pharmacokinetic study of ioxaglate, a low osmolality contrast medium, in patients with renal failure. Int. J. Clin. Pharmacol. Ther. Toxicol. 1986; 11: 614
  • Corradi A., Menta R., Cambi V., Maccarini P., Cerutti R. Pharmacokinetics of iopamidol in adults with renal failure. Arzneimittelforschung 1990; 40: 830
  • Donnelly P. K., Burwell N., McBurney A., Ward J. W., Walls J., Watkin E. M. Clearance of iopamidol, a non-ionic contrast medium, by CAPD in patients with end-stage renal failure. Br. J. Radiol. 1992; 65: 1108
  • Donnelly P. K., Burwell N., McBurney A., Ward J. W., Walls J., Watkin E. M. Hemodialysis and iopamidol clearance after subclavian venography. Invest. Radiol. 1993; 28: 629
  • Evans J. R., Cutler R. E., Forland S. C. Pharmacokinetics of iothalamate in endstage renal disease. J. Clin. Pharmacol. 1988; 28: 826
  • Goodfellow T., Holdstock G. E., Brunton F. J., Bamforth J. Fatal acute vasculitis after high-dose urography with iohexol. Br. J. Radiol. 1986; 59: 620
  • Gouge S. F., Moore J., Jr, Atkins F., Hirszel P., Cory J. Radiocontrast removal by dialysis membranes. Blood Purif. 1991; 9: 182
  • Hansson R., Lindholm T. Elimination of Hypaque (sodium-3,5-diacetamido-2,4,6-triiodobenzoate) and the effect of haemodialysis in anuria. Acta Med. Scand. 1963; 174: 611
  • Harasawa H., Yamazaki C., Masuko K. Side effects and pharmacokinetics of nonionic iodinated contrast medium in hemodialyzed patients. Nippon Acta Radiol. 1990; 50: 1524
  • Heydenreich C., Larsen P. O. Iododerma after high dose urography in an oliguric patient. Br. J. Dermatol. 1977; 97: 567
  • Kierdorf H., Kindler J., Winterscheid R., Hollmann H. J., Voorwerk D., Speck U. Elimination of the non-ionic contrast medium iopromide in end-stage renal failure by hemodialysis. Kidn. Urin. Tract 1989; 128: 119
  • Levine E., Grantham J. J., Slusher S. L., Greathouse J. L., Krohn B. P. CT of acquired cystic kidney disease and renal tumors in long-term dialysis patients. AJR 1984; 142: 125
  • Maher J. F. Pharmacokinetics in patients with renal failure. Clin. Nephrol. 1984; 21: 39
  • Morris T. W., Katzberg R. W. Intravascular contrast media. The contrast media manual, R. W. Katzberg. Williams & Wilkins, Baltimore 1992; 1
  • Mützel W., Siefert H.-M., Speck U. Biochemical-pharmacologic properties of iohexol. Acta Radiol. 1980; 111, Suppl. 362
  • Rivera M., Teruel J. L., Castaño J. C., Otero G. G., Ortuño J. Iodine-induced sialoadenitis. Report of 4 cases and review of the literature. Nephron 1992; 63: 466
  • Speck U. X-ray contrast media. Overview, use and pharmaceutical aspects. Springer-Verlag, Berlin 1991
  • Swanson D. P., Thrall J. H., Shetty P. C. Evaluation of intravascular low-osmolality contrast agents. Clin. Pharm. 1986; 5: 877
  • Waaler A., Svaland M., Fauchald P., Jakobsen J. Å., Kolmannskog F., Berg K. J. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure. Nephron 1990; 56: 81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.